Therefore, the ALK translocations in thyroid carcinoma represents an interesting therapeutic approach especially because such translocations are over-represented in clinically aggressive thyroid carcinomas and could be inactivated in combination with targeted therapies or chemotherapies to block the resistance mechanisms [130]. Here, ALK is linked to thyroid gland carcinoma.